Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate with β-TCP in Periodontal Intra-osseous Defects
NCT02795546Phase 4Completed
- Sponsor
- Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
- Start
- Jan 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of alendronate in periodontal intra-osseous defects (2 arms), sponsored by Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre. Primary endpoint: Linear bone growth at 6 months. Started Jan 2015; status: completed.
02
Drugs
alendronate
03
Conditions
periodontal intra-osseous defects
Beyond the preview
Go deeper on NCT02795546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02795546.